← All Sponsors
SPONSOR

SWOG Cancer Research Network

Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8Stage II Pancreatic Neuroendocrine Tumor AJCC v8Stage III Pancreatic Neuroendocrine Tumor AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu NegativeProgesterone Receptor PositivePrognostic Stage IV Breast Cancer AJCC v8
NCT05040360 Phase 2
Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Metastatic Malignant Neoplasm in the Liver
United States, Mexico, Uruguay View Trial →
NCT03723928
Recruiting

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8
United States, Guam, Puerto Rico View Trial →
NCT05642572 Phase 2
Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma
United States View Trial →